To further investigate the carcinogenic mechanism of NSUN2 in NPC, 88 patients in GSE102349 were divided into the NSUN2-low expression group (n = 61) and the NSUN2-high expression group (n = 27). This evidence concerns the gene NSUN2 and nasopharyngeal carcinoma.